BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6295252)

  • 21. [Specific immunostimulation in the therapy of recurrent herpes simplex type I or II].
    Veneroni G; Calixte C; Bozzo Costa E; Germogli R
    Boll Ist Sieroter Milan; 1987; 66(6):427-34. PubMed ID: 2839208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunology of herpesvirus infection: immunity to herpes simplex virus in eye infections.
    Meyers RL; Chitjian PA
    Surv Ophthalmol; 1976; 21(2):194-204. PubMed ID: 185741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.
    Donnenberg AD; Chaikof E; Aurelian L
    Infect Immun; 1980 Oct; 30(1):99-109. PubMed ID: 6254886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis.
    Metcalf JF; Kaufman HE
    Am J Ophthalmol; 1976 Dec; 82(6):827-34. PubMed ID: 187060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental herpetic keratitis in the guinea pig.
    Tabbara KF; Okumoto M; Smolin G
    Can J Ophthalmol; 1974 Jul; 9(3):363-6. PubMed ID: 4367538
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on red blood cell-mediated immunity of patients with recurrent stromal herpes simplex keratitis].
    Yang C
    Zhonghua Yan Ke Za Zhi; 1995 Jan; 31(1):43-4. PubMed ID: 7781425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological responses of patients with recurrent herpes genitalis.
    Sirianni MC; Bonomo R; Scarpati B; Soddu S; Panà A; Turbessi G; Cherchi M; Aiuti F
    Diagn Immunol; 1986; 4(6):294-8. PubMed ID: 3493109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ocular herpes. Correlations between subpopulations of T lymphocytes and clinical manifestations?].
    Colin J; Youinou P; Miossec P; Pennec Y
    J Fr Ophtalmol; 1982; 5(11):665-8. PubMed ID: 6984052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study.
    Easty D; Entwistle C; Funk A; Witcher J
    Trans Ophthalmol Soc U K (1962); 1975 Jul; 95(2):267-76. PubMed ID: 775699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell mediated immunity in herpes simplex keratitis in man.
    Saini JS; Datta U; Pradhan D
    Acta Ophthalmol (Copenh); 1990 Oct; 68(5):519-24. PubMed ID: 2275344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated immune response in anaplasmosis as measured by a micro cell-mediated cytotoxicity assay and leukocyte migration-inhibition test.
    Buening GM
    Am J Vet Res; 1976 Oct; 37(10):1215-8. PubMed ID: 984549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of 80 virologically-confirmed cases of ocular herpes. Study of the correlation between the type of virus and the epidemiologic characteristics of the disease].
    Colin J; Chastel C; Coroller A; Lejeune B; Quillien MC; Querre J
    J Fr Ophtalmol; 1983; 6(11):877-80. PubMed ID: 6323567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of a mixed herpes-viral and tubercular allergy in the pathogenesis of ophthalmic herpes].
    Slepova OS; Murav'eva TV
    Oftalmol Zh; 1981; 36(3):139-42. PubMed ID: 6269039
    [No Abstract]   [Full Text] [Related]  

  • 35. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
    Crivii SM; Crişan M; Crişan M
    Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological assay in herpes simplex keratitis].
    Wu LX
    Zhonghua Yan Ke Za Zhi; 1984 Nov; 20(6):324-6. PubMed ID: 6442680
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
    Donnenberg AD; Bell RB; Aurelian L
    Cell Immunol; 1980 Dec; 56(2):526-39. PubMed ID: 6258811
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunoprofile studies in patients with pulmonary tuberculosis. I. Correlation of pretherapy cellular tests with characteristics of the disease.
    Skvor J; Trnka L
    Scand J Respir Dis; 1979 Aug; 60(4):161-7. PubMed ID: 394313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modeling chronic herpetic keratitis].
    Zaĭtseva NS; Krichevskaia GI; Schcheglovitova ON; Blinova LI; Kasparov AA
    Vestn Akad Med Nauk SSSR; 1973; 28(2):53-7. PubMed ID: 4359445
    [No Abstract]   [Full Text] [Related]  

  • 40. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
    Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
    Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.